-
read more
August 3, 2023
Genesis Hospitality Pastry Chef Invited To Attend Prestigious Culinary Master Class in Switzerland.
-
read more
January 5, 2023
Chez Alice Patisserie opens a new location in Downtown Lambertville.
-
read more
August 19, 2022
Lambertville Station Restaurant and Inn Hosting Fall Fest
-
read more
July 14, 2022
The Perch at Peacock Inn in Princeton, NJ, earns Wine Spectator Award of Excellence
-
read more
May 10, 2022
Lambertville Station Restaurant and Inn Receives 2022 Best of Lambertville Award
-
read more
January 19, 2022
Lambertville Station Restaurant and Inn Named Winner in 2022 WeddingWire Couples’ Choice Awards®
-
read more
November 9, 2021
Genesis Hospitality Acquires Iconic Lambertville Station Restaurant and Inn.
-
read more
April 27, 2021
Chez Alice Patisserie Receives 2021 Best of Princeton Award
-
read more
September 18, 2019
The Peacock Inn Restaurant & Bar Debuts French Provencal Cuisine
-
read more
September 27, 2018
The Peacock Inn Restaurant & Bar Introduces Afternoon Tea Service
-
read more
August 8, 2018
The Peacock Inn Restaurant & Bar Announces New Sommelier
-
read more
June 12, 2018
The Peacock Inn Receives AAA Four Diamond Award
-
read more
May 24, 2018
The Peacock Inn Restaurant & Bar Announces New Executive Chef
-
read more
May 18, 2018
Under New Ownership, The Peacock Inn Restaurant & Bar Celebrates Grand Reopening
-
read more
September 1, 2024
Genesis Drug Discovery & Development to attend Gene Therapy for Ophthalmic Disorders Summit in Boston
-
read more
July 1, 2024
Genesis Drug Discovery & Development Appoints Madeline Farley, Ph.D. as Chief Scientific Officer of the Biochemistry and Bioanalytical Division
-
read more
June 13, 2024
Exhibitor at the ASM-Microbe 2024 Conference in Atlanta, GA
June 13-17 -
read more
May 9, 2024
Exhibitor at the ARVO 2024 Vision for the Future Conference in Seattle, WA
May 5-9 -
read more
May 1, 2024
Genesis Drug Discovery & Development Attends The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Seattle
-
read more
March 10, 2024
Exhibitor at the Society of Toxicology (SOT) 63rd Annual Meeting and ToxExpo in Salt Lake City, Utah
March 10–14 -
read more
March 1, 2024
Genesis Drug Discovery & Development Attends Society of Toxicology Annual Meeting in Salt Lake City
-
read more
February 1, 2024
Genesis Drug Discovery & Development Appoints Anthony Rohr, B.S., LATG, CLSSBB as Director of Business Development
-
read more
July 1, 2023
Genesis Drug Discovery & Development Appoints Christopher Dillion, B.A., LATG, CPIA as Chief Operating Officer.
-
read more
June 1, 2023
Genesis Drug Discovery & Development Appoints Madeline Farley, Ph.D., as Managing Member of PharmOptima
-
read more
May 10, 2023
Genesis Drug Discovery & Development (GD3), a member of Genesis Global Group, acquires JSS Medical Research to expand its clinical services portfolio.
-
read more
January 10, 2023
Genesis Axis Acquires Organochem to Grow the Preclinical Chemistry Services Portfolio.
-
read more
October 7, 2021
Genesis Biotechnology Group Acquires BioBlocks to Grow the Preclinical Chemistry Services Portfolio of Genesis Drug Discovery & Development (GD3)
-
read more
May 26, 2021
Medical Diagnostic Laboratories, L.L.C., Announces New Line of Dermatopathology Testing including Melanoma Hereditary Genetics
-
read more
March 9, 2021
Medical Diagnostic Laboratories, L.L.C., Announces New Line of Urology Testing including Prostate Cancer and Renal Cancer Hereditary Genetics
-
read more
March 4, 2021
Genesis Drug Discovery and Development acquires Integrated Analytical Solutions to add “off the shelf” PK profiling capabilities to its portfolio
-
read more
January 6, 2021
Genesis Drug Discovery and Development expands its presence in the clinical space by acquiring STATKING Clinical Services
-
read more
December 9, 2020
Genesis Biotechnology Group announces second year of CRO relationship with Yale University
-
read more
September 16, 2020
Genesis Drug Discovery & Development Appoints Laura Sailor Veteran CRO Business Development Leader as Director of Business Development
-
read more
September 16, 2020
Genesis Drug Discovery & Development Appoints Anthony Rohr as Chief Operating Officer
-
read more
September 16, 2020
Genesis Biotechnology Group Appoints Erich E. Dagnal as Director of Mergers & Acquisitions
-
read more
August 5, 2020
Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services
-
read more
August 4, 2020
Genesis Drug Discovery & Development (GD3) Announces Appointment of Anthony Rohr, as Chief Executive Officer of PharmOptima
-
read more
May 19, 2020
Medical Diagnostic Laboratories, L.L.C., Expands Availability of Coronavirus Disease 2019 (COVID-19) Testing into New York and Increases Testing Capabilities
-
read more
April 29, 2020
Medical Diagnostic Laboratories, L.L.C., Launches Serological Test for Coronavirus Disease 2019 (COVID-19) Antibodies in Human Serum.
-
read more
November 19, 2019
Genesis Biotechnology Group acquires NEDP to grow the Preclinical Chemistry services portfolio of Genesis Drug Discovery & Development (GD3)
-
read more
September 24, 2019
Genesis Biotechnology Group® (GBG) Announces First Annual Community Fall Fest in Hamilton
-
read more
June 18, 2019
Genesis Drug Discovery & Development Expands Preclinical Contract Research Portfolio by Acquiring NexusPharma
-
read more
March 18, 2019
Medical Diagnostic Laboratories, L.L.C., Fights Tick- and Mosquito-borne Epidemic with New Comprehensive Testing for Vector-borne Disease.
-
read more
February 27, 2019
Genesis Drug Discovery & Development Announces Operating Agreement with Ophthy-DS, Inc.
-
read more
October 30, 2018
Genesis Biotechnology Group announces partnership with Yale University
-
read more
July 19, 2018
Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer
-
read more
April 29, 2018
Abstract accepted for Presentation at The Association for Research in Vision and Ophthalmology (ARVO) 2018 Annual Meeting April 29 - May 03, 2018 in Honolulu, Hawaii
-
read more
August 3, 2017
Genesis Biotechnology Group® Acquires Assets of 4path, Ltd to Expand their Diagnostic Branch
-
read more
March 1, 2017
Genesis Biotechnology Group Expands Preclinical Contract Research Portfolio by Acquiring PharmOptima
-
read more
December 9, 2016
Mercer County Community College has launched a partnership with GBG to give students the opportunity to work while they learn
-
read more
March 1, 2015
Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Test
-
read more
May 21, 2012
Mercer Regional Chamber of Commerce 2011 Award
-
read more
April 10, 2012
Announcing new testing for Aerobic Vaginitis (AV)
-
read more
April 2, 2012
A Complimentary Reflex Test to Determine Metronidazole Resistance in Trichomonas vaginalis.
-
read more
July 27, 2011
New Bacterial Vaginosis/Lactobacillus Profiling Assay
-
read more
July 20, 2011
New HPV-16 Status Test
-
read more
January 1, 2010
Biotech Company Sponsors International Bacterial Vaginosis Symposium to Continue Support of Women's Health
-
read more
March 22, 2022
Elissa J. Santoro, MD Renowned Breast Surgeon Joins Montclair Breast Center
-
read more
August 4, 2021
Genesis Biotechnology Group acquires Montclair Breast Center
-
read more
November 23, 2015
BioPlast Manufacturing to Acquire Kord-Valmark Petri Dish Manufacturing Line
-
read more
April 3, 2019
Genesis Investment Properties Announces Pre-Leasing at Genesis Village